Corneal transplantation is the most successful of organ transplants du
e to the fact that the eye is an immunologically privileged site, and
the cornea is an immunologically privileged tissue. The factors respon
sible for this include presence of the blood-aqueous barrier, the avas
cularity of the cornea, the absence of classic antigen-presenting cell
s (APCs) in the central cornea, inhibitory factors in the aqueous humo
r, the phenomenon known as anterior chamber-associated immune deviatio
n (ACAID), and the intraocular expression of Fas ligand. Loss of ocula
r immune privilege can occur with breaching of the blood-ocular barrie
r, corneal neovascularization, migration of classic APCs to the center
of the cornea, loss of inhibitory factors in aqueous humor, abrogatio
n of ACAID, and loss of Fas ligand expression within the anterior cham
ber. The purpose of this review is to analyze these events and how the
y relate to corneal graft rejection. A discussion on future research a
nd therapeutic modalities is provided.